Astrana Health [ASTH] vs Surgery Partners [SGRY] Detailed Stock Comparison

Astrana Health Inc.

NASDAQ
Loading...

Surgery Partners Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Astrana Health Inc. wins in 10 metrics, Surgery Partners Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Astrana Health Inc. Surgery Partners Inc. Better
P/E Ratio (TTM) 73.30 2,956.00 Astrana Health Inc.
Price-to-Book Ratio 2.12 1.09 Surgery Partners Inc.
Debt-to-Equity Ratio 193.10 114.51 Surgery Partners Inc.
PEG Ratio -0.41 -34.35 Astrana Health Inc.
EV/EBITDA 14.57 11.42 Surgery Partners Inc.
Profit Margin (TTM) 0.71% -2.35% Astrana Health Inc.
Operating Margin (TTM) 1.85% 15.09% Surgery Partners Inc.
EBITDA Margin (TTM) 1.85% 15.09% Surgery Partners Inc.
Return on Equity 4.49% 2.76% Astrana Health Inc.
Return on Assets (TTM) 3.43% 3.74% Surgery Partners Inc.
Free Cash Flow (TTM) $104.49M $195.60M Surgery Partners Inc.
1-Year Return 51.75% -43.41% Astrana Health Inc.
Price-to-Sales Ratio (TTM) 0.59 0.57 Surgery Partners Inc.
Enterprise Value $2.10B $7.49B Surgery Partners Inc.
EV/Revenue Ratio 0.66 2.26 Astrana Health Inc.
Gross Profit Margin (TTM) 10.00% 23.98% Surgery Partners Inc.
Revenue per Share (TTM) $65 $26 Astrana Health Inc.
Earnings per Share (Diluted) $0.46 $-0.61 Astrana Health Inc.
Beta (Stock Volatility) 0.77 1.99 Astrana Health Inc.
Short % of Float 8.35% 22.70% Astrana Health Inc.

Astrana Health Inc. vs Surgery Partners Inc. Stock Performance Analysis

Loading Price Chart...

ASTH
SGRY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astrana Health Inc.-0.65%-4.23%5.52%40.24%61.74%46.35%
Surgery Partners Inc.-1.89%2.45%-2.96%-13.22%-17.78%-9.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astrana Health Inc.51.75%11.50%1.87%585.25%637.65%637.65%
Surgery Partners Inc.-43.41%-66.42%-77.94%-5.72%-27.51%-27.51%

Performance & Financial Health Analysis: Astrana Health Inc. vs Surgery Partners Inc.

MetricASTHSGRY
Market Information
Market Cap i$1.88B$1.86B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i497,178864,264
90 Day Avg. Volume i435,2831,150,188
Last Close$36.67$13.51
52 Week Range$18.08 - $39.93$11.41 - $24.10
% from 52W High-8.16%-43.94%
All-Time High$133.23 (Nov 15, 2021)$69.58 (Jun 21, 2021)
% from All-Time High-72.48%-80.58%
Growth Metrics
Quarterly Revenue Growth0.43%0.02%
Quarterly Earnings Growth0.43%0.02%
Financial Health
Profit Margin (TTM) i0.01%-0.02%
Operating Margin (TTM) i0.02%0.15%
Return on Equity (TTM) i0.04%0.03%
Debt to Equity (MRQ) i193.10114.51
Cash & Liquidity
Book Value per Share (MRQ)$15.94$13.37
Cash per Share (MRQ)$8.68$1.87
Operating Cash Flow (TTM) i$114.60M$274.30M
Levered Free Cash Flow (TTM) i$227.95M$164.71M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Astrana Health Inc. vs Surgery Partners Inc.

MetricASTH (Apr 26, 2026)SGRY (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i73.302,956.00
Forward P/E i10.5037.68
PEG Ratio i-0.41-34.35
Price to Sales (TTM) i0.590.57
Price to Book (MRQ) i2.121.09
Market Capitalization
Market Capitalization i$1.88B$1.86B
Enterprise Value i$2.10B$7.49B
Enterprise Value Metrics
Enterprise to Revenue i0.662.26
Enterprise to EBITDA i14.5711.42
Risk & Other Metrics
Beta i0.771.99
Book Value per Share (MRQ) i$15.94$13.37

Financial Statements Comparison: Astrana Health Inc. vs Surgery Partners Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASTH (2025)SGRY (2025)
Revenue/Sales i3.18B3.31B
Cost of Goods Sold i2.84B2.54B
COGS % of Revenue i89.3%76.9%
Gross Profit i341.53M765.00M
Gross Margin i10.7%23.1%
Research & Development iN/AN/A
Operating Income (EBIT) i78.53M470.80M
Operating Margin i2.5%14.2%
EBITDA i135.35M678.40M
EBITDA Margin i4.3%20.5%
Pre-Tax Income i39.61M116.90M
Pre-Tax Income % of Revenue i1.2%3.5%
Income Tax i15.53M18.00M
Income Tax % of Revenue i0.5%0.5%
Net Income (Profit) i24.08M98.90M
Profit Margin i0.8%3.0%

Balance Sheet & Liquidity Metrics

MetricASTH (2025)SGRY (2025)
Cash & Equivalents i429.47M239.90M
Total Current Assets i863.31M1.15B
Total Current Assets % of Revenue i27.1%34.8%
Total Current Liabilities i615.27M615.50M
Total Current Liabilities % of Revenue i19.3%18.6%
Long-Term Debt i1.02B3.88B
Long-Term Debt % of Revenue i32.1%117.4%
Total Shareholders Equity i558.33M3.53B
Retained Earnings i308.38M-815.20M
Retained Earnings % of Revenue i9.7%-24.6%
Property, Plant & Equipment i35.74M1.60B

Cash Flow Statement Comparison

MetricASTH (2025)SGRY (2025)
Operating Cash Flow i109.88M243.40M
Operating Cash Flow % of Revenue i3.5%7.4%
Capital Expenditures i-10.11M-32.20M
Free Cash Flow i104.49M195.60M
FCF Margin i3.3%5.9%
Debt Repayment i-495.29M-1.04B
Common Stock Repurchase i-15.43MN/A

Short Interest & Institutional Ownership Analysis

MetricASTHSGRY
Shares Short i2.68M14.00M
Short Ratio i6.867.57
Short % of Float i8.35%22.70%
Shares Outstanding i48.89M129.32M
Float Shares i44.36M55.54M
% Held by Insiders i20.32%1.53%
% Held by Institutions i52.52%122.23%
% Held by Public i27.16%-23.76%

Dividend Analysis & Yield Comparison: Astrana Health Inc. vs Surgery Partners Inc.

MetricASTHSGRY
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A